Skip to content
777 Sourcing.

Capability

immuno-oncology drug development

Suppliers
2
States & provinces
2
Countries
1

2 immuno-oncology drug development suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

APTEVO THERAPEUTICS INC

SEATTLE, WA

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company based in Seattle, Washington, focused on developing novel bispecific and trispecific immunotherapies for the treatment of cancer. The company leverages its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.

bispecific and trispecific immunotherapy developmentclinical developmentpreclinical researchproprietary ADAPTIR and ADAPTIR-FLEX platforms

Compiled from public sources

COHERUS ONCOLOGY, INC.

REDWOOD CITY, CA

Coherus Oncology is a commercial-stage company focused on developing and commercializing a diversified portfolio of next-generation immuno-oncology therapies that target the tumor microenvironment and potentially extend patient survival across tumor types. Its FDA-approved therapy LOQTORZI (toripalimab-tpzi) treats recurrent, locally advanced or metastatic nasopharyngeal carcinoma in combination with chemotherapy or as a single agent. The company has multiple clinical-stage immuno-oncology candidates and ongoing clinical trials across cancer indications.

clinical trialscommercializationmanufacturing and supply chain managementmarketing

Compiled from public sources

Related capabilities

Other processes offered by the shops that list immuno-oncology drug development.

Browse all capabilities